WHO’s adolescent obesity guideline sets a six-month multimodal gateway before pharmacotherapy, shaping evidence expectations and access pathways. https://www.mattheneus.com/editorial/who-adolescent-obesity-guideline-six-month-multimodal-pharmacotherapy-pathway-2026-10-07 #HTA #HealthEconomics #RegulatoryAffairs
#regulatoryaffairs — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #regulatoryaffairs, aggregated by home.social.
-
How should staged access to healthcare AI connect with economic appraisal? The UK's 44-point plan makes that question operational. https://www.mattheneus.com/editorial/uk-healthcare-artificial-intelligence-staged-access-economic-appraisal-2026-10-06 #HTA #HealthEconomics #RegulatoryAffairs
-
Four decisions can give patient-relevant outcomes a clear route into health technology assessment. https://www.mattheneus.com/editorial/ispor-patient-relevant-outcomes-four-stage-hta-framework-2026-10-06 #HTA #HealthEconomics #RegulatoryAffairs
-
German assessment narrows Alyftrek's benefit signal to one cystic fibrosis genotype group, highlighting how subgroup evidence shapes HTA conclusions. https://www.mattheneus.com/editorial/iqwig-alyftrek-cystic-fibrosis-fmf-severe-exacerbation-signal-2026-10-01 #HTA #HealthEconomics #RegulatoryAffairs
-
Germany’s final depemokimab decision highlights the evidentiary cost of an active-biologic comparator gap in severe nasal polyposis. https://www.mattheneus.com/editorial/g-ba-depemokimab-crswnp-final-resolution-active-biologic-comparator-gap-2026-10-01 #HTA #Pharma #RegulatoryAffairs